INTRODUCTION
There has been a great development in practice of urology with the progressive shift from laparoscopic to robotic surgery in past few decades. Single-site surgery is a great leap since the introduction to laparoscopic/robotic surgery. The first surgery using single-port as reported by Hirano et al. was retroperitoneoscopic adrenalectomy in 2005. [3] Robotic laparoendoscopic single-site (R-LESS) has undergone remarkable growth since inception, and it addresses numerous issues associated with its predecessor, LESS. There is a significant enhancement in optics and ergonomics. Reports also conclude improved cosmesis and reduced incidence of postoperative complications such as abdominal adhesions and incisional hernias with single-port surgery. At present, R-LESS is applied in various urological procedures, including nephrectomy (partial, simple, and radical), pyeloplasty, nephroureterectomy, prostatectomy, and sacrocolpopexy.
Even though R-LESS is still an evolutionary technique, efforts are made to address common complaints regarding difficulties of triangulation and instrument clashing. [2] Numerous efforts are made to overcome these hindrances by developing flexible endoscopes, curved trocars, semi-rigid robotic instruments, multichannel ports, and seven-degree wrist movement of the robotic instruments. The surgical approach has been reconfigured. The extraperitoneal and perineal approach has shown intelligent advantage because of the ability to maneuver the instrument arm about its axis without moving each individual arm. Our group has recently published preclinical study using such approaches. [4] The aim of this paper is to analyze the current status of R-LESS and to discuss its future.
MATERIALS AND METHODS
By searching PubMed selectively for relevant articles, we concluded a literature review. The keywords used in our search were robotic laparoscopic single incision, robotic laparoendoscopic single-site, single incision robotic surgery, and R-LESS. We identified 36 related articles in specifically in the field of urology. We selectively chose only those that pertained to single-site robotic surgery in urology.
RESULTS
We identified and reviewed 36 articles on R-LESS in the field of urology [ Table 1 ]. Although there are substantially more in circulation describing R-LESS use in such procedures as cholecystectomy, colectomy, and hysterectomy we focused on those concentrating on urology. The very first report of R-LESS was in 2008 by Kaouk et al. of three patients describing three different urologic procedures using the da Vinci S robotic platform through a multichannel single-port. [5] These three first R-LESS procedures opened the gateway to advance this technique and was driven by the enthusiasm of decreasing the need for visible scars, decreasing postoperative pain during major abdominal surgery. It was also reported that using the robot did enhance surgeon experience, and eased the technicalities of the surgical procedures compared to pure LESS technique. However, this was not without limitations. The first generation da Vinci platform occupied substantial space extracorporeally which caused clashing of the arms and inhibited triangulation which was necessary for laparoscopic surgery. This lack of triangulation was described as "chopstick" that occurs due to the lack of wrist movement. [1] The few studies that were published the following year in 2009 began to develop the R-LESS using the similar platform. The use of the GelPort was an effort to decrease the problems with the triangulation and arm clashing that was the ever present problem. [7] The access site for the robot did continue to be one of the primary issues with the robotic platform at that time. Won Lee et al. described using a glove size seven, and an Alexis wound retractor (Applied Medical, Rancho Santa Margarita, CA, USA) to facilitate further movement and flexibility of the robotic arms but was met with issues such as tearing the glove, loss of air pressure and increased operative time. [17] Advancements also took place with regards to the robotic instruments. In 2010, our group first described the use of the VeSPA instruments and accessories in a preclinical study in pigs. These instruments were rigid as the standard da Vinci arms were, which allowed them to be flexed and crossed at the fascial level with the aid of curved cannulae. Furthermore, introduced in this study was a newly designed specific-purpose multichannel single-port. The software for the new instruments allowed the right robotic arm to be controlled by the surgeon's left hand and vice versa. This eliminated the issues with triangulation. However, these first generation instruments restricted surgeon's freedom and ability of wrist articulation. Soon after, the implementation of slightly shorter trocars and more flexible instruments were redesigned. These second-generation improvements enhanced the laparoscopic environment [ Figure 1 ].
The feasibility of R-LESS for partial nephrectomy in cases with larger tumor burden was first done by Tiu et al. in [5] Robotic SP transumbilical surgery in humans: Initial report 3 Series study using R-LESS technique in 1 radical prostatectomy, 1 dismembered pyeloplasty, and 1 RN 2 2009 Kaouk and Goel [6] SP laparoscopic and robotic PN 7 Retrospective review of 7 patients. 5 underwent single-port laparoscopic PN, and 2 patients underwent single-port robotic PN 3 2010 Stein et al. [7] R-LESS using GelPort as the access platform 4 Series study using R-LESS technique in 2 pyeloplasties, 1 RN, and 1 PN 4 2010 Joseph et al. [1] "Chopstick" surgery: A novel technique improves surgeon performance and eliminates arm collision in robotic single-incision laparoscopic surgery NA 5 surgeons performed 3 different laparoscopic skills and that were monitored, graded, and timed 5 2010 White et al. [8] R-LESS 2 Review article of current literature 6 2010 Haber et al. [9] Novel robotic da Vinci instruments for LESS 16 Series study using R-LESS technique in 4 pyeloplasties, 4 partial nephrectomies, and 8 nephrectomies in a total of 8 farm pigs 7 2010 White et al. [10] R-LESS radical prostatectomy: Technique and early outcomes 20 Retrospective comparative analysis of 10 patients in an R-LESS nephrectomy arm, and 10 patients in a conventional laparoscopy arm 8 2011 White et al. [11] R-LESS RN: Surgical technique and comparative outcomes 10 Retrospective review of 10 patients that underwent R-LESS RN. Compared with matched control group of 10 patients who underwent conventional LESS 9 2011 Spana et al. [12] Is robotics the future of LESS?
Review article 10 2011 Kaouk et al. [13] LESS in urology: Worldwide multi-institutional analysis of 1076 cases 143 Large multi-institutional worldwide series of LESS surgeries. In 143 (13%) the da Vinci robot was used during a portion of the procedure. 1076 were included in the entire study 11 2011 Han et al. [14] Robot-assisted laparoscopic single-site surgery: PN for renal malignancy 16 Retrospective review of 14 cases of R-LESS-PN after 2 were excluded for having AML or XGP 12 2011 Rane and Autorino [15] Robotic natural orifice translumenal endoscopic surgery and LESS: Current status NA Review article of current literature 13 2012 Olweny et al. [16] Perioperative comparison of robotic-assisted LESS pyeloplasty versus conventional LESS pyeloplasty 15 Retrospective comparative analysis of twenty patients that underwent pyeloplasty. Ten patients in the R-LESS arm, and ten patients in the conventional LESS arm 14 2011 Won Lee et al. [17] Urologic robot-assisted LESS using a homade SP device: A single center experience of 68 cases 68 Retrospective review of 68 R-LESS cases using a homemade device. Fifty-one partial nephrectomies, 12 nephroureterectomies, 3 nephrectomies, 2 adrenalectomies 15 2012 Cestari et al. [18] Feasibility and preliminary clinical outcomes of R-LESS pyeloplasty using a new SP platform 9 Retrospective review of nine patients who underwent R-LESS pyeloplasty with the da Vinci single-site platform (multichannel single-port with two curved cannulas) 16 2012 White et al. [19] R-LESS: The way forward NA Review article of current literature 17 2012 White et al. [20] R-LESS urological survey: Analysis of 50 consecutive cases 50 Retrospective review of 50 patients who underwent R-LESS. 24 patients underwent renal surgery, 26 patients underwent pelvic surgery 18 2013 Tiu et al. [21] Feasibility of R-LESS PN for renal tumors >4 cm 67 Retrospective comparative study of 67 patients who underwent R-LESS PN, stratified into 2 groups ->4 cm and ≤4 cm 19 2012 Kaouk et al. [22] Robotic single-site kidney surgery: Evaluation of second-generation instruments in a cadaver model 3 Preclinical cadaveric study. 1 pyeloplasty, 1 radical, and 1 partial nephrectomies 20 2012 Verit el al. [23] R-LESS: From present to future NA Review article of current literature 21 2012 Seideman et al. [24] Robot-assisted LESS pyeloplasty: Technique using the da Vinci Si robotic platform 10 Series study using R-LESS technique in 10 pyeloplasty cases outlining surgeon experience 22 2013 Tobis et al. [25] Robot-assisted transumbilical LESS pyeloplasty: Technique and perioperative outcomes from a Single Institution 8 Case series study of 8 patients who underwent R-LESS pyeloplasty 23 2014 Jung et al. [26] Simultaneous robot-assisted LESS-PN and standard radical prostatectomy 3 Case series study-3 patients who underwent simultaneous R-LESS pyeloplasty and radical prostatectomy 24 2013 Merseburger et al. [27] EAU guidelines on robotic and single-site surgery in urology NA Review of current literature, and suggested guidelines 25 2014 Mathieu et al. [28] Robotic-assisted LESS-RN: First experience with the novel da Vinci single-site platform 6 First clinical series of 6 R-LESS radical nephrectomies with the novel R-LESS da Vinci platform 26 2014 Komninos et al. [29] R-LESS PN trifecta outcome is inferior to multiport robotic PN: Comparative analysis 58 Retrospective comparative analysis. 58 total patients.
Multiport trifecta was seen in 38 patients, 42.7% while the R-LESS group trifecta was seen in 20 patients, 25.6%
Contd... 2012. [21] In this retrospective study, patients were stratified into two groups depending on size either >4 m or ≤4 cm. The study reported safety of R-LESS in tumors >4 cm but with longer warm ischemia times (WITs) and length of stay in patients with higher mean nephrometry scores. It was only in 2013 that Komninos et al. published the Trifecta outcome study after partial nephrectomies (i.e., WIT <20 min, negative surgical margins, and no surgical complications) showing inferior outcomes for R-LESS compared to multiport surgery. [29] Even though total operation time and WIT are longer in R-LESS, the effect on renal eGFR return was only short-term. The ultimate return of renal function was influenced by the amount of renal mass preserved. [31] A prospective study of 19 patients that underwent R-LESS in 2010 with published results in 2014 after 3-year follow-up. [35] This study was the first direct clinical application showing feasibility and safety in human population. The latest and perhaps the most dynamic innovation have yet to be released. Preclinical trials are currently undergoing and two studies have described the new purpose-built single-port robotic SP 1098 [ Figures 2 and 3] . [4] This system holds promise to overcome difficulties with previous techniques and instrumentation.
Urology Annals
This new platform permits three instruments, and an 8 mm camera, which all individually articulate, to utilize a single 25 mm port. The SP 1098 is designed to be compatible with the Xi side cart. As described by Ramirez et al. and Maurice et al. the excellence of this design allows instruments to be deployed through at 25 mm port intracorporeally while maintaining all seven degrees of freedom at the wrist. [4, 38] These two preclinical studies show that this platform allows complex procedures to be feasible and eliminates several of the previous limitations.
DISCUSSION
The advantages of R-LESS are undisputable with shorter recovery times and less postoperative pain with better cosmetic outcomes. The major shortcomings with the initial laparoscopic single-port surgery were instrument clashing, difficulties with triangulation. This led to single-port surgery attempted with the multiport standard platform with the da Vini S and Si models with the introduction of Gelport. Unfortunately, the robotic arms still limited the triangulation angle which the VeSPA system and automatic instrument reversal techniques showed less external clashing problems but with the sacrifice of wrist movement. What was necessitated was a complete [30] Current status and future directions of robotic single-site surgery: A systematic review NA Review article of current literature 28 2014 Komninos et al. [31] Robotic-assisted LESS partial nephrectomy with the novel da Vinci single-site platform: Initial experience 3 Series study using R-LESS technique in 3 partial nephrectomies, specifically using the novel R-LESS da Vinci platform 29 2014 Shin et al. [32] LESS RAPN reduces postoperative wound pain without a rise in complication rates 167 Retrospective comparative analysis. 167 patients, 80 patients in the multiport robotic PN group and 79 in the R-LESS PN group 30 2014 Lim et al. [33] LESS robotic-assisted nephroureterectomy:
Comparison with conventional multiport technique in the management of upper urinary tract urothelial carcinoma 38 Retrospective comparative analysis. A total of 38 patients included in study, 17 in the R-LESS, and 21 in the multiport 31 2015 Buffi et al. [34] Robotic-assisted, single-site, dismembered pyeloplasty for ureteropelvic junction obstruction with the new da Vinci platform: A Stage 2a study 30 Prospective study of 30 patients who were chosen, from 2 institutions, to undergo R-LESS pyeloplasty. Feasibility, safety, and efficacy were endpoints 32 2014 Kaouk et al. [35] A novel robotic system for SP urologic surgery: First clinical investigation 19 Prospective study of 19 patients with 3-year follow-up. 11 radical prostatectomies, 4 partial nephrectomies, 4 nephrectomies 33 2014 Samarasekera and Kaouk [36] Robotic single-port surgery: Current status and future considerations NA Review article of current literature 34 2016 Lee [37] Robotic single-site sacrocolpopexy: First report and technique using the single-site wristed needle driver 6 Series study of 6 patients 35 2017 Maurice et al. [38] R-LESS retroperitoneal renal surgery: Initial investigation of a purpose-built SP surgical system 9 Cadaveric series study including 9 procedures. 1 nephrectomy performed, and bilateral partial nephrectomies were performed on 4 cadavers 36 2016 Ramirez et al. [4] Robotic perineal radical prostatectomy and pelvic lymph node dissection using a purpose-built SP robotic platform 3 Preclinical study demonstrating the feasibility of performing perineal radical prostatectomy with pelvic lymph node dissection using the purpose-built da Vinci model SP 1098 change in the entire robotic platform. This progression of technological need gave birth to the novel da Vinci SP 1098 platform. Specifically developed for single-site surgery is still in preclinical research phase. [4, 38] The endowrist technology introduced in 2015 has been a step forward to avoid difficulties with triangulation especially/more so in surgeries with multiple sutures and knot tying. [37] Limitations of R-LESS as reported include a steep learning curve and the level of expertise required to perform these procedures. Moreover, the majority of the studies to date are retrospective analysis with very few prospective studies in small group of patients.
CONCLUSION
Although feasibility and better outcomes are reported with less invasive single-port, there still remains a concern for the demonstration of a clear advantage of single-port over the conventional robotic surgery. There are improvements in technology-mostly that robotic interface is being used now compared to laparoscopy, and that a purpose-built robot is now being developed. Hence with new technology, the authors believe the field of single-port surgery will move toward more efficient surgeries and more innovational operative techniques. Whether such techniques will impact outcomes and decrease morbidity has yet to be seen.
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